U.S. market Open. Closes in 1 hour 7 minutes

WGS | GeneDx Holdings Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue202.57M234.69M212.19M179.32M196.17M
Cost of Revenue141.94M261.44M228.80M175.30M113.39M
Gross Profit60.62M-26.75M-16.60M4.03M82.78M
Operating Expenses224.28M430.76M429.55M246.02M113.20M
Selling, General & Admin165.50M338.24M318.73M163.93M68.84M
Research & Development51.56M86.20M105.16M72.70M34.91M
Other Operating Expenses-7.22M6.31M5.66M9.39M9.45M
Operating Income-163.66M-667.65M-446.15M-241.99M-30.41M
Other Expenses / Income-13.03M69.62M200.76M654.00K709.00K
Before Tax Income-176.69M-598.03M-245.39M-241.34M-29.70M
Income Tax Expenses-926.00K-49.05M21.57M5.10M1.29M
Net Income-175.77M-548.98M-245.39M-246.44M-30.99M
Interest ExpensesN/A3.21M2.83M2.47M783.00K
Basic Shares Outstanding24.31M10.24M3.28M155.007.28M
Diluted Shares Outstanding24.31M10.24M3.28M155.007.28M
EBITDA-127.83M-395.60M-424.34M-227.13M-22.51M
EBITDA Margin-63.10%-168.56%-199.98%-126.66%-11.48%
EBIT-176.69M-594.83M-220.98M-238.87M-28.92M
EBIT Margin-87.23%-253.45%-104.14%-133.21%-14.74%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙